ARCHIVES

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

This article is from The Cancer Letter archive.

Vol. 12 No. 25 | June 20, 1986

Download PDF Visit The Full Archive

Related Articles

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

November 29, 2002

HCFA Sees Applications For DRGs And Research

September 27, 1985

Michelle Le Beau named director of University of Chicago Cancer Research Center.

May 7, 2004

Letter: The Lesson From Dana-Farber

July 28, 1995

Marijuana-Derived Drug Less Effective Than Standard

March 29, 2002

NCi Advisors Approve New SPORE Grant Program In Cancer Communications.

December 1, 2000